Gaudenz joined Cellestia as the Chief Financial Officer in 2017. He has more than 20 years of experience in the field of strategic, operational and financial management for several public and private companies. Before joining Cellestia, Gaudenz was the CFO of PIQUR Therapeutics AG. Prior to that he was the CFO at Helvetica Property Investors AG, an asset management advisor. He had a leading role in raising over $ 400 million in equity and debt.
“My relationship with Cellestia started as a Seed investor. As my understanding of what this team is able to achieve grew, I knew I wanted to be a part of the journey.”
In his earlier career, he held finance and management positions at UBS and Carbogen Amcis. He obtained his degree in Finance, Economics and Management from the University of Applied Sciences in Basel.